Kadmon Corporation, LLC-Product Pipeline Review-2015

Kadmon Corporation, LLC-Product Pipeline Review-2015

  • Products Id :- GMDHC06785CDB
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Kadmon Corporation, LLC-Product Pipeline Review-2015


Global Markets Direct's, 'Kadmon Corporation, LLC-Product Pipeline Review-2015', provides an overview of the Kadmon Corporation, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Kadmon Corporation, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Kadmon Corporation, LLC including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Kadmon Corporation, LLC's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Kadmon Corporation, LLC's pipeline products

Reasons To Buy

Evaluate Kadmon Corporation, LLC's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Kadmon Corporation, LLC in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Kadmon Corporation, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Kadmon Corporation, LLC and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kadmon Corporation, LLC

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Kadmon Corporation, LLC and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Kadmon Corporation, LLC Snapshot 6

Kadmon Corporation, LLC Overview 6

Key Information 6

Key Facts 6

Kadmon Corporation, LLC-Research and Development Overview 7

Key Therapeutic Areas 7

Kadmon Corporation, LLC-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Kadmon Corporation, LLC-Pipeline Products Glance 12

Kadmon Corporation, LLC-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Kadmon Corporation, LLC-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Kadmon Corporation, LLC-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Kadmon Corporation, LLC-Drug Profiles 17

KD-019 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

KD-020 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

KD-025 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

KD-026 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

salirasib 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

CHX42-H8 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Gene Therapy to Activate Aquaporin-1 for Xerostomia 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

KD-014 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

KD-033 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

KL-00148 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

KL-00199 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

KL-10742 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Monoclonal Antibody to Inhibit VEGFR-2 for Colorectal Cancer 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

Small Molecule to Inhibit pan-ROCK 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

Small Molecule to Selectively Inhibit ROCK2 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

Small Molecules to Inhibit Acetyl-CoA Carboxylase for CMV Infections 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

Kadmon Corporation, LLC-Pipeline Analysis 35

Kadmon Corporation, LLC-Pipeline Products by Target 35

Kadmon Corporation, LLC-Pipeline Products by Route of Administration 37

Kadmon Corporation, LLC-Pipeline Products by Molecule Type 38

Kadmon Corporation, LLC-Pipeline Products by Mechanism of Action 39

Kadmon Corporation, LLC-Recent Pipeline Updates 40

Kadmon Corporation, LLC-Dormant Projects 44

Kadmon Corporation, LLC-Locations And Subsidiaries 45

Head Office 45

Other Locations & Subsidiaries 45

Appendix 46

Methodology 46

Coverage 46

Secondary Research 46

Primary Research 46

Expert Panel Validation 46

Contact Us 46

Disclaimer 47

List of Tables

Kadmon Corporation, LLC, Key Information 6

Kadmon Corporation, LLC, Key Facts 6

Kadmon Corporation, LLC-Pipeline by Indication, 2015 8

Kadmon Corporation, LLC-Pipeline by Stage of Development, 2015 10

Kadmon Corporation, LLC-Monotherapy Products in Pipeline, 2015 11

Kadmon Corporation, LLC-Phase III, 2015 12

Kadmon Corporation, LLC-Phase II, 2015 13

Kadmon Corporation, LLC-Phase I, 2015 14

Kadmon Corporation, LLC-Preclinical, 2015 15

Kadmon Corporation, LLC-Discovery, 2015 16

Kadmon Corporation, LLC-Pipeline by Target, 2015 36

Kadmon Corporation, LLC-Pipeline by Route of Administration, 2015 37

Kadmon Corporation, LLC-Pipeline by Molecule Type, 2015 38

Kadmon Corporation, LLC-Pipeline Products by Mechanism of Action, 2015 39

Kadmon Corporation, LLC-Recent Pipeline Updates, 2015 40

Kadmon Corporation, LLC-Dormant Developmental Projects,2015 44

Kadmon Corporation, LLC, Other Locations 45

Kadmon Corporation, LLC, Subsidiaries 45

List of Figures

Kadmon Corporation, LLC-Pipeline by Top 10 Indication, 2015 8

Kadmon Corporation, LLC-Pipeline by Stage of Development, 2015 10

Kadmon Corporation, LLC-Monotherapy Products in Pipeline, 2015 11

Kadmon Corporation, LLC-Pipeline by Top 10 Target, 2015 35

Kadmon Corporation, LLC-Pipeline by Top 10 Route of Administration, 2015 37

Kadmon Corporation, LLC-Pipeline by Top 10 Molecule Type, 2015 38

Kadmon Corporation, LLC-Pipeline Products by Top 10 Mechanism of Action, 2015 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of Kadmon Corporation, LLC; Kadmon Corporation, LLC - Key Therapeutics; Kadmon Corporation, LLC - Pipeline Overview and Promising Molecules; Kadmon Corporation, LLC - News; Kadmon Corporation, LLC - Latest Updates; Kadmon Corporation, LLC - Pipeline; Kadmon Corporation, LLC - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101175
Site License
USD 3000 INR 202350
Corporate User License
USD 4500 INR 303525



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com